BeOne Medicines (ONC) Current Leases (2019 - 2026)
BeOne Medicines (ONC) posted quarterly Current Leases of $20.6 million for Q1 2026, up 12.46% year-over-year from $18.3 million in Q1 2025, and down 0.55% quarter-over-quarter from $20.7 million in Q4 2025.
BeOne Medicines (ONC) Current Leases (2019 - 2026) Analysis & Trends
BeOne Medicines (ONC) has reported Current Leases for 8 consecutive years, with $20.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Leases rose 12.46% year-over-year to $20.6 million; the TTM figure through Mar 2026 stood at $20.6 million (up 12.46% YoY), while the FY2025 annual figure was $20.7 million, up 17.76% from the prior year.
- Current Leases fell to $20.6 million in Q1 2026 per ONC's latest filing, from $20.7 million in the prior quarter.
- Across five years, Current Leases topped out at $24.8 million in Q2 2022 and bottomed at $15.7 million in Q3 2025.
- Historically, Current Leases has averaged $20.8 million across 5 years, with a median of $20.7 million in 2025.
- Annual changes were most pronounced in 2022 — Current Leases soared 63.61% — and 2024, when it declined 24.89%.
- BeOne Medicines' Current Leases stood at $24.0 million in 2022, then retreated by 8.7% to $22.0 million in 2023, then retreated by 19.93% to $17.6 million in 2024, then grew by 17.76% to $20.7 million in 2025, then slipped by 0.55% to $20.6 million in 2026.
- Business Quant data shows ONC's Current Leases at $20.6 million in Q1 2026, $20.7 million in Q4 2025, and $15.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | 12.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21.95 Mn |
| Mar 31, 2026 | 20.58 Mn |
| Dec 31, 2025 | 20.70 Mn |
| Sep 30, 2025 | 15.73 Mn |
| Jun 30, 2025 | 17.25 Mn |
| Mar 31, 2025 | 18.30 Mn |
| Dec 31, 2024 | 17.58 Mn |
| Sep 30, 2024 | 17.71 Mn |
| Jun 30, 2024 | 17.66 Mn |
| Mar 31, 2024 | 19.40 Mn |
| Dec 31, 2023 | 21.95 Mn |
| Sep 30, 2023 | 23.25 Mn |
| Jun 30, 2023 | 23.51 Mn |
| Mar 31, 2023 | 24.55 Mn |
| Dec 31, 2022 | 24.04 Mn |
| Sep 30, 2022 | 24.34 Mn |
| Jun 30, 2022 | 24.79 Mn |
| Mar 31, 2022 | 22.89 Mn |
| Dec 31, 2021 | 21.93 Mn |
| Sep 30, 2021 | 18.64 Mn |